117 related articles for article (PubMed ID: 38224723)
1. Therapeutic effects of coptisine derivative EHLJ7 on colorectal cancer by inhibiting PI3K/AKT pathway.
Chai C; Tang X; Chi X; Li X; Zhang H; Wu L
Cell Signal; 2024 Apr; 116():111053. PubMed ID: 38224723
[TBL] [Abstract][Full Text] [Related]
2. Coptisine-induced apoptosis in human colon cancer cells (HCT-116) is mediated by PI3K/Akt and mitochondrial-associated apoptotic pathway.
Han B; Jiang P; Li Z; Yu Y; Huang T; Ye X; Li X
Phytomedicine; 2018 Sep; 48():152-160. PubMed ID: 30195873
[TBL] [Abstract][Full Text] [Related]
3. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
4. Patrinia villosa treat colorectal cancer by activating PI3K/Akt signaling pathway.
Li XC; Wang S; Yang XX; Li TJ; Gu JX; Zhao L; Bao YR; Meng XS
J Ethnopharmacol; 2023 Jun; 309():116264. PubMed ID: 36868440
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumour effect of Huangqin Decoction on colorectal cancer mice through microbial butyrate mediated PI3K/Akt pathway suppression.
Zhu JJ; Liu HY; Yang LJ; Fang Z; Fu R; Chen JB; Liu S; Fei BY
J Med Microbiol; 2023 May; 72(5):. PubMed ID: 37195736
[No Abstract] [Full Text] [Related]
6. Berberine Inhibited Growth and Migration of Human Colon Cancer Cell Lines by Increasing Phosphatase and Tensin and Inhibiting Aquaporins 1, 3 and 5 Expressions.
Tarawneh N; Hamadneh L; Abu-Irmaileh B; Shraideh Z; Bustanji Y; Abdalla S
Molecules; 2023 Apr; 28(9):. PubMed ID: 37175233
[No Abstract] [Full Text] [Related]
7. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
Li Y; Peng F; Tan X; Wang J; Xu Y
Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
[TBL] [Abstract][Full Text] [Related]
9. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
10. Bioactive triterpenes of jujube in the prevention of colorectal cancer and their molecular mechanism research.
Ruan J; Li H; Lu M; Hao M; Sun F; Yu H; Zhang Y; Wang T
Phytomedicine; 2023 Feb; 110():154639. PubMed ID: 36608502
[TBL] [Abstract][Full Text] [Related]
11. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
Yin F; Huang X; Xuan Y
Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway.
Hu D; Meng RY; Nguyen TV; Chai OH; Park BH; Lee JS; Kim SM
Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36382656
[TBL] [Abstract][Full Text] [Related]
13. Deoxyshikonin isolated from
Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
[No Abstract] [Full Text] [Related]
14. LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.
Liu B; Pan S; Xiao Y; Liu Q; Xu J; Jia L
J Exp Clin Cancer Res; 2018 Dec; 37(1):316. PubMed ID: 30547804
[TBL] [Abstract][Full Text] [Related]
15. Xanthones from
Lu MQ; Ruan JY; Li HM; Yang DS; Liu YX; Hao MM; Yu HY; Zhang Y; Wang T
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768602
[TBL] [Abstract][Full Text] [Related]
16. Butyric Acid Increases the Therapeutic Effect of EHLJ7 on Ulcerative Colitis by Inhibiting JAK2/STAT3/SOCS1 Signaling Pathway.
Tang X; Li X; Wang Y; Zhang Z; Deng A; Wang W; Zhang H; Qin H; Wu L
Front Pharmacol; 2019; 10():1553. PubMed ID: 32038241
[TBL] [Abstract][Full Text] [Related]
17. [
Liu J; Shen W; Cheng H; Fan M; Xiao J; Xu C; Tan J; Lai Y; Yu C; Sun D; Li L
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1452-1461. PubMed ID: 36329578
[TBL] [Abstract][Full Text] [Related]
18. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/Akt/mTOR signaling pathway].
Tao SN; Liu XC; Wang YY; Yang H
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):758-765. PubMed ID: 38462356
[No Abstract] [Full Text] [Related]
19. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
20. Calycosin suppresses colorectal cancer progression by targeting ERβ, upregulating PTEN, and inhibiting PI3K/Akt signal pathway.
Zhu L; Liu S; Liao YF; Sheng YM; He JC; Cai ZX; Man Q; Wu YY
Cell Biol Int; 2022 Sep; 46(9):1367-1377. PubMed ID: 35842774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
